1. Introduction {#sec1}
===============

*Pouzolzia indica* Gaudich.var. *angustifolia* Wedd. (local name "Non tai baihong") is a Thai medicinal plant in the family Urticaceae \[[@B1], [@B2]\]. It was used as remedy for the ailments in female infertility, cancer, and inflammation and as emmenagogue and insecticide \[[@B3]\]. The chemical constituents in*P*. *indica* were scarcely reported. Only lanceolone, an isoflavone compounds, was isolated \[[@B4]\]. Previously, the antiproliferative effect of the methanolic part of this plant was reported \[[@B5]\]. It could inhibit the growth of NB4 and HT93A cells with the IC~50~ values of 28.5 ± 0.1 and 49.8 ± 0.7 *μ*g/mL \[[@B5]\], respectively. The apoptosis of NB4 cells treated with 75 *μ*g/mL of this fraction for 24 hours increased from 3.2% to 22.2%, whereas HT93A cells underwent apoptosis from 3.0% to 51.3% when treated with the methanolic part at 150 *μ*g/mL \[[@B5]\]. The previous results, therefore, showed high potent antiproliferative effect of this methanolic part on these acute leukemic cells. From this study, the active extract was further fractionated using column chromatography. The active fractions were determined by bioassay. The compounds in each fraction were isolated and structurally identified.

2. Materials and Methods {#sec2}
========================

2.1. Cytotoxicity Test {#sec2.1}
----------------------

### 2.1.1. Cell Lines and Culture {#sec2.1.1}

NB4 promyelocytic cell line was kindly provided by Ms. Setsuko Miyanishi, Tenri Institute of Medical Research, Japan, and HT93A promyelocytic cell line was kindly provided by Dr. Kenji Kishi, Tokai University, Japan. Long and short types of PML-RAR*α* have been detected in NB4 and HT93A cells, respectively \[[@B6]--[@B8]\]. Cells were maintained in RPMI 1640 media supplemented with 10% fetal bovine serum (Stem cell Technology, Vancouver, BC, Canada) with 1% penicillin and streptomycin (Gibco, Life Technologies, Breda, the Netherlands). Cells were incubated at 37°C with 95% humidified atmosphere containing 5% CO~2~ \[[@B9]\].

### 2.1.2. Cell Viability Assay {#sec2.1.2}

Cell viability was assessed using MTT \[(3,4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide\] assay \[[@B10]\]. In brief, 1 × 10^4^ cells of NB4 and 1 × 10^5^ cells of HT93A were seeded in each well in 96-well plate flat bottom. Cells were treated with each fraction isolated from this medicinal plant for 48 h at the concentrations varying from 0 to 50 *μ*g/mL. After 48 h incubation, 50 *μ*L of 1 mg/mL of MTT in PBS (Sigma, Thailand) was added to each well, and cells were incubated for 4 hr. 100 *μ*L of 10% SDS in 0.01 M HCl was added to stop the reaction and was incubated overnight. The absorbance at 590 nm was measured and read using the ELISA reader (Biorad, USA). Cell viability was calculated using the following formula \[[@B11]\]: $$\begin{matrix}
{\text{Cell}{\,\,}\text{viability}{\,\,}\left( \% \right) = \left( \frac{\text{sample}{\,\,}\text{OD}}{\text{control}{\,\,}\text{OD}} \right) \times 100.} \\
\end{matrix}$$

### 2.1.3. Statistical Analysis {#sec2.1.3}

The experiments were performed in triplicate with three independent experiments. Data were expressed as the mean ± standard deviation. The *R*-square equation was used to calculate the IC~50~ value. A *P* value less than 0.05 was considered statistically significance \[[@B9]\].

2.2. Phytochemistry {#sec2.2}
-------------------

### 2.2.1. General {#sec2.2.1}

^1^H and ^13^C NMR spectra recorded on Bruker DPX-300, Switzerland, with deuterated solvents and TMS as a reference. APCI-MS atmospheric pressure chemical ionization mass spectra were measured on Perkin Elmer mass spectrometer. IR spectra were recorded on FT-IR spectrometer; Perkin-Elmer UV spectra were recorded on Hitachi, U 320 spectrophotometer. Melting points were measured on Digital Electromol 9100. Separation and isolation were performed by column chromatography (CC) using following adsorbents: Diaion HP20, size 250--850 *μ*m, Mitsubishi Chemical Industry, silica gel for CC (63--200 *μ*m, Merck 7734), and low pressure column chromatography (LiChroprep, Merck). TLC: precoated Kieselgel 60 F~254~ (Merck). NP/PEG or NEU spray reagent was used to detect flavonoids and coumarins, 10% H~2~SO~4~ in ethanol was used as universal spray reagent, and 10% FeCl~3~ in ethanol was used to detect phenolic compounds.

### 2.2.2. Plant Material {#sec2.2.2}

The aerial parts of *P. indica* were collected from Ratchaburi Province in the central part of Thailand. The plant was identified by the expert from Forest Herbarium-BKF, Bangkok, Thailand. A plant specimen was deposited with the voucher number of BKF. no. 106441 and SN 096588.

### 2.2.3. Extraction and Isolation {#sec2.2.3}

*P. indica* was extracted with ethanol and fractionated by Diaion HP20 column, eluted with water, water : methanol (1 : 1), methanol, and ethyl acetate. The methanol fraction showed significant antiproliferative effect \[[@B5]\]. This active methanolic part (16 g) was applied on a silica gel column, eluted with gradient solvent systems (ss) of hexane-ethyl acetate and ethyl acetate-methanol, to obtain 5 fractions (FFI--FFV). FFI (2.5 g, ss : hexane-EtOAc, 9 : 1) appeared as oily liquid. FFII (0.35 g, ss : hexane-EtOAc, 1 : 1), FFIII (3.30 g, ss : hexane-EtOAc, 1 : 9), FFIV (3.87 g, ss : EtOAc-MeOH, 8 : 2), and FFV (5.37 g, ss : EtOAc-MeOH, 7 : 3). The bioassay-guided fractionation showed the active fractions, that is, FFII--FFIV. FFII--FFIV were further separated by chromatographic column ([Figure 1](#fig1){ref-type="fig"}). FFII was chromatographed on silica gel column, eluted with gradient ss of hexane-acetone and acetone-methanol, to obtain 3 subfractions FFII-1-3. FFII-1 (0.06 g, ss : hexane-Me~2~O, 95 : 5) appeared as oily liquid. FFII-2 (0.19 g, ss : hexane-Me~2~O, 8 : 2) was recrystallized with Et~2~O, and the white needles **1** (15 mg) was obtained. The filtrate was evaporated to dryness and recrystallized with methanol, and **2** (10 mg) was obtained. FFII-3 (0.018 g) was separated on the preparative TLC using solvent system of hexane : CH~2~Cl~2~ : methanol (50 : 50 : 2) giving four separated bands. The band with *R* ~*f*~ value of 0.75 was isolated, recrystallized in ethyl acetate resulting **3** (5 mg).

FFIII was chromatographed on silica gel column, eluted with gradient ss of hexane-CH~2~Cl~2~ and CH~2~Cl~2~-methanol, to obtain 5 subfractions FFIII-1--5. FFIII-1 (0.19 g, ss : hexane-CH~2~Cl~2~, 7 : 3) was recrystallized in methanol giving **4** (15 mg). FFIII-2 (0.465 g, ss : hexane-CH~2~Cl~2~, 1 : 1) was recrystallized with methanol giving **5** (15 mg). FFIII-3 (0.146 g, ss : CH~2~Cl~2~-MeOH, 9.5 : 0.5) was recrystallized in methanol giving **6** (12 mg). FFIII-4 (0.06 g, ss : CH~2~Cl~2~-MeOH, 9 : 1) was brown gum. FFIII-5 (1.09 g, ss : CH~2~Cl~2~-MeOH, 8 : 2) appeared as yellowish gum.

FFIV was chromatographed on silica gel column, eluted with gradient ss of hexane-acetone and acetone-methanol. It produced 2 subfractions, that is, FFIV-1-2. FFIV-1 (2.33 g, ss : hexane : acetone, 7 : 3) was added with methanol, **7** (85 mg) was precipitated as white powder. FFIV-2 (1.297 g, ss : acetone : methanol, 9 : 1) was added with chloroform : methanol (95 : 5);**8** (20 mg) was obtained as white powder. Each of the purified compounds **1**--**8** described above possessed the following physicochemical properties and the chemical structures were identified using spectroscopic methods (^1^H NMR, ^13^C NMR, Mass spectra, IR spectra, and UV-spectra). The structure of compounds **1**--**8** ([Figure 2](#fig2){ref-type="fig"}) were elucidated as the followings:

1.  (friedelin): white needles (Me~2~O). mp 258--260°C. UV (EtOH) *λ* ~max⁡~ 220 nm. IR (CHCl~3~) *ν* ~max⁡~ 2980, 2927, 2870 (CH), 1706 (C=O), 1462, 1389 (CH) cm^−1^. APCI-MS 427.4156 \[M+H\]^+^ (calc. C~30~H~50~O 426.7244). ^1^H NMR (CDCl~3~, 300 MHz) *δ* 0.75 (3H, s, H-24), 0.90 (3H, s, H-23), 0.98 (3H, s, H-25), 1.04 (3H, s, H-29) 1.04 (3H, s, H-30), 1.04 (3H, s, H-26), 1.07 (3H, s, H-27), 1.20 (3H, s, H-28), 1.3-1.4 (18H, complex m, H-6, 7, 11, 12, 15, 16, 19, 21, 22), 1.4--1.6 (3H, complex m, H-8, 10, 18), 1.74 (2H, dd, *J*5.5, 3.0 Hz, H-1a, H-1b), 2.2 (1H, m, H-4), 2.34 (1H, m, H-2b), 2.40 (1H, m, H-2a). ^13^C NMR (CDCl~3~, 75 MHz) *δ* 213.1(C3), 59.4 (C10), 58.2 (C4), 53.1 (C8), 42.8 (C18), 42.0 (C5), 41.5 (C6), 41.5 (C2), 39.7 (C13), 39.2 (C22), 38.3 (C14), 37.4 (C9), 36.0 (C16), 35.6 (C11), 35.3 (C19), 35.0 (C29), 32.8 (C21), 32.4 (C15), 32.1 (C28), 31.8 (C30), 30.5 (C12), 30.0 (C17), 28.1 (C20), 22.2 (C1), 20.2 (C26), 18.6 (C27), 18.2 (C7), 17.9 (C25), 14.6 (C24), 6.8 (C23) \[[@B12]--[@B14]\].

2.  (28-hydroxy-3-friedelanone or canophyllol): white prisms (MeOH). mp 363-364°C. UV (EtOH) *λ* ~max⁡~ 220 nm. IR (CHCl~3~) *ν* ~max⁡~ 3200--3513 (OH), 1709 (C=O), 2990, 2930, 2855 (C--H), 1466, 1378 (C--H) and 1039, 1116 (C--O). APCI-MS 443.4015 \[M+H\]^+^ (calc. C~30~H~50~O~2~ 442.5038). ^1^H NMR (CDCl~3~, 300 MHz) *δ* 0.88 (3H, s, H-24), 0.91 (3H, d, *J*7.8 Hz, H-23), 0.99 (3H, s, H-25), 1.02 (3H, s, H-26) 1.01 (3H, s, H-27), 1.19 (3H, s, H-29), 1.23 (3H, s, H-30), 1.3-1.4 (18H, complex m, H-6, 7, 11, 12, 15, 16, 19, 21, 22), 1.4--1.6 (3H, complex m, H-8, 10, 18), 1.96 (2H, dd, *J* 7.6, 3.7 Hz, H-1a, H-1b), 2.32 (1H, m, H-2b), 2.30 (1H, m, H-4), 2.40 (1H, m, H-2a) and 2.5 (2H, m, H-28), 3.71 (1H, 28-OH). ^13^C-NMR (CDCl~3~, 75 MHz) *δ* 213.1 (C3), 68.3 (C28), 59.4 (C10), 58.2 (C4), 53.1 (C8), 42.0 (C5), 41.7 (C22), 41.5 (C2, C6), 39.7 (C13), 39.5 (C18), 38.3 (C14), 37.4 (C9), 35.6 (C11), 35.2 (C17), 34.4 (C29), 33.4 (C19), 32.9 (C30), 31.6 (C21), 31.3 (C16), 30.5 (C12), 30.3 (C20), 29.2 (C15), 23.4 (C1), 19.4 (C25), 19.1 (C26), 18.2 (C7), 18.1 (C27), 14.8 (C24), 6.8 (C23) \[[@B13], [@B14]\].

3.  (7-methoxy-coumarin or herniarin): white needles (MeOH). mp 117-118°C. UV (MeOH) *λ* ~max⁡~ 254, 366 nm. IR (CHCl~3~) *ν* ~max⁡~ 2927, 2870 (CH), 1682 (C=O), 1533 (C=C) cm^−1^. APCI-MS 176.2015 \[M\]^+^ (calc C~10~H~8~O~3~ 176.1714). ^1^H NMR (CDCl~3~, 300 MHz) *δ* 7.63 (1H, d, *J* 9.6 Hz, H-4), 6.31 (1H, d, *J* 9.6 Hz, H-3), 7.09 (1H, d, *J* 8 Hz, H-5), 6.95 (1H, s, H-8), 6.90 (1H, d, *J* 8 Hz, H-6) and 3.99 (3H, s, 7-OCH~3~). ^13^C NMR (CDCl~3~ 75 MHz) *δ* 162.02 (C2), 156.3 (C7), 150.0 (C8a), 142.7 (C4), 121.1 (C3), 115.2 (C4a), 113.4 (C6), 111.4 (C8), 109.1 (C5), 56.3 (OCH~3~) \[[@B15], [@B16]\].

4.  (6, 7-dimethoxy-coumarin or scoparone): pale yellow needles (MeOH). mp 146-147°C. UV (MeOH) *λ* ~max⁡~ 345 nm. IR (CHCl~3~) *ν* ~max⁡~ 2985, 2925, 2855 (CH), 1684 (C=O), 1535 (C=C), 1462, 1389, 1363 and 1311 (CH). APCI-MS 206.1245 \[M\]^+^ (calc. C~11~H~10~O~4~ 206.1576). ^1^H NMR (CDCl~3~, 300 MHz) *δ*, 7.63 (1H, d,*J* 9.5 Hz, H-4), 6.9 (1H, s, H-5), 6.85 (1H, s, H-8), 6.25 (1H, d,*J* 9.5 Hz, H-3), 3.90 (3H, s, 7-OCH~3~), 3.85 (3H, s, 6-OCH~3~). ^13^C-NMR (CDCl~3~, 75 MHz) *δ* 161.3 (C2), 152.9 (C7), 150.1 (C6), 146.4 (8a), 143.2 (C4), 113.6 (C3), 111.5 (C4a), 108.20 (C5), 100.1(C8), 56.40 (2xOCH~3~) \[[@B15], [@B17]\].

5.  (6-methoxy-7-hydroxy-coumarin or scopoletin): pale yellow needles (CH~2~Cl~2~ : MeOH: 9.5 : 0.5). mp 203-204°C. UV (MeOH) *λ* ~max⁡~ 254, 366 nm. IR (CHCl~3~) *ν* ~max⁡~ 3400--3550 (OH), 1685 (C=O), 2998, 2938, 2856 (CH), 1589, 1511 (C=C) cm^−1^. APCI-MS 192.2008 \[M\]^+^ (calc. C~10~H~8~O~4~192.1708). ^1^H NMR (CDCl~3~, 300 MHz) *δ* 7.61 (1H, d,*J* 9.5 Hz, H-4), 6.90 (1H, s, H-5), 6.85 (1H, s, H-8), 6.28 (1H, d,*J*9.5 Hz, H-3) and 3.85 (3H, s, 6-OCH~3~). ^13^C NMR (CDCl~3~, 75 MHz) *δ* 161.5 (C2), 150.2 (C6), 149.7 (C7), 144.0 (C8a), 143.4 (C4), 113.4 (C3), 111.5 (C4a), 107.5 (C5), 103.2 (C8), 56.4 (OCH~3~) \[[@B16], [@B17]\].

6.  ((E)-methyl-3 (3′,4′-dihydroxy-phenyl) acrylate or methyl caffeate): pale yellow crystalline powder (MeOH). mp 157--159°C. UV (MeOH) *λ* ~max⁡~ 354 nm. IR (CHCl~3~) *ν* ~max⁡~ 3530 (OH), 2995, 2927, 2870 (CH), 1516, 1643 (C=C) and 1690 (C=O). APCI-MS 194.0623 \[M\]^+^ (calc. C~10~H~10~O~4~ 194.1866). ^1^H NMR (CDCl~3~, 300 MHz) *δ* 7.50 (1H, d, *J* 16.1 Hz, H-3), 7.17 (1H, d, *J* 2 Hz, H-2′), 6.93 (1H, d,*J* 7 Hz, H-5′), 6.88 (1H, dd, *J*7, 2 Hz, H-6′), 6.15 (1H, d,*J* 16.1 Hz, H-2), 3.85 (3H, s, OCH~3~). ^13^C NMR (CDCl~3~-CD~3~OD, 75 MHz) *δ* 168.3 (C1), 147.4 (C4′), 145.5 (C3), 144.8 (C3′), 126.6 (C1′), 121.8 (C2), 115.1 (C2′), 114.1 (C5′), 113.9 (C6′), 51.4 (OCH~3~) \[[@B18], [@B19]\].

7.  (sitosteryl glucoside): white needles (MeOH). mp 258--260°C. UV (EtOH) *λ* ~max⁡~ 220 nm. IR (KBr) *ν* ~max⁡~ 3200--3450 (OH), 2980, 2927, 2870 (CH), 1560 (C=C). APCI-MS 412.4002 \[M − 180\]^+^ (calc. C~35~H~60~O~6~ 576.8854. ^1^H NMR (CDCl~3~+CD~3~OD, 300 MHz) *δ* 0.59 (3H, s, H-18), 0.85 (3H, d,*J* 7.3 Hz, H-27), 0.90 (3H, t,*J* 6.5, 6.5 Hz, H-29), 0.91 (3H, s, H-19), 0.92 (3H, d,*J* 7.3 Hz, H-26), 1.12 (3H, d,*J* 7.0 Hz, H-21), 1.30 (2H, m, H-28), 1.74 (1H, m, H-2a), 1.94 (2H, m, H-1), 2.18 (1H, m, H-2b), 2.21 (1H, m, H-4), 3.28--3.5 (5H, m,H-1′, H-2′, H-3′ H-4′, H-5′), 3.50--3.70 (2H, m, H-6′). 3.74 (1H, m, H-3), 5.31 (1H, m, H-6), ^13^C NMR (CDCl~3~+CD~3~OD, 75 MHz) *δ* 140.1 (C5), 121.9 (C6), 100.9 (C1′), 79.0 (C3, C3′), 76.2 (C5′), 75.7 (C2′), 73.4 (C4′), 61.8 (C6′), 56.6 (C20), 55.9 (C17, C24), 50.0 (C9), 45.6 (C8), 42.1 (C13), 40.0 (C12), 39.9 (C4), 37.5 (C1), 36.5 (C10), 33.8 (C7, C22), 31.7 (C14), 29.8 (C2), 29.4 (C16), 29.0 (C25), 28.0 (C23), 24.1 (C15), 23.0 (C28), 22.9 (C11, C21), 20.9 (C26), 19.5 (C27), 19.0 (C19), 11.7 (C29), 11.6 (C18) \[[@B16]\].

8.  (a supposed glycosphingolipid): white amorphous powder (CHCl~3~ :  MeOH, 3 : 97). mp 252-254°C (MeOH). UV (EtOH) *λ* ~max⁡~ 236 nm, IR (KBr) *ν* ~max⁡~ 3230-3450 (OH), 3384 (NH), 2998, 2935, 2851(CH), 1642 (C=O). APCI-MS 751.2596 \[M\]^+^(calc. C~44~H~81~NO~8~ 751.2539). ^1^H NMR (pyr-d~5~, 300 MHz) *δ* 0.90 (2 × 3H, t, J6, 6 Hz, acyl-CH~3~), 1.20 (2H, m, H-17), 1.30 (complex m, H7-16, (CH~2~)~*n*~), 1.8 (6H, m, H-6, H-3′, H-6′), 2.4 (2H, m, H-2′), 2.6-2.8 (1H, m, OH), 3.90-4.50 (7H, m, H-1′′, H-2′′, H-3′′, H-4′′, H-5′′, H-6′′). 4.24 (1H, m, H-1a), 4.66 (1H,m, H-1b), 4.70 (1H, m, H-5′), 4.75 (2H, m, H-2, H-3), 5.30 (1H, m, H-5, H-4′), 5.50 (1H, dd, J6.6, 1.0 Hz, H-4), 6-8 (4H, br, s, 4xOH), 8.59 (1H, d, J9.2 Hz, NH). ^13^C NMR (pyr-d~5~, 75 MHz) *δ* 175.7 (C1′), 130.9 (C4), 130.7 (C4′), 123.8 (C5), 122.0 (C5′), 105.6 (C1′′), 78.6 (C3′′), 78.4 (C5′′), 75.4 (C2′′), 72.5 (C3), 71.8 (C4′′), 70.5 (C1), 63.0 (C6′′), 57.7 (C2), 34.3 (C2′), 33.3 (C3′), 32.2 (C6, C6′), 29.6 (C7-C16, C7′-(CH~2~)′~*n*~), 22.9 (C17), 14.3 (acyl CH~3~), 14.1 (acyl CH~3~) \[ 20-23 \].

3. Results {#sec3}
==========

The antiproliferative effect of FFI--FFV on human leukemic cell lines was investigated as shown in [Figure 3](#fig3){ref-type="fig"}. It was found that FFII, FFIII, and FFIV could inhibit growth of NB4 and HT93A ([Figure 4](#fig4){ref-type="fig"}). Therefore, FFII, FFIII, and FFIV were continued to evaluate the IC~50~ values on these cell lines at varying concentrations ranging from 0 to 50 *μ*g/mL. The results showed that FFII, FFIII, and FFIV had the IC~50~ values on NB4 cell line at 15.1 ± 0.5 *μ*g/mL, 14.4 ± 0.6, and 32.1 ± 0.7 *μ*g/mL, respectively, whereas the IC~50~ values of the HT93A cell line were 31.0 ± 0.1, 9.7 ± 1.3, and 10.5 ± 0.7 *μ*g/mL, respectively, as shown in [Figure 4](#fig4){ref-type="fig"}. Additionally, FFIII inhibited growth strongly on both NB4 and HT93A cell lines, while FFII inhibits growth strongly on NB4 more than HT93A. FFIV showed strong growth inhibition on HT93A more than NB4.

The active fractions FFII, FFIII, and FFIV were further chromatographed on the silica gel columns repeatedly, and the isolated compounds were identified using spectroscopic methods. FFII was composed of friedelin **1** and 28-hydroxy-3-friedelanone **2** and 7-methoxy-coumarin or herniarin **3**. FFIII was composed of 6,7-dimethoxy-coumarin or scoparone **4**, scopoletin **5**, and methyl caffeate **6**. FFIV was composed of sitosteryl glucoside **7**and a supposed glycosphingolipid **8**. Sitosteryl glucoside **7** (85 mg) was isolated which was the highest yield as shown in [Figure 1](#fig1){ref-type="fig"}.

4. Discussion {#sec4}
=============

*P. indica*, which has been long used in Thai traditional medicine for treating various diseases including malignancies, was investigated in this study. Based on our previous report \[[@B5]\], the methanolic part of this plant showed high potent antiproliferative effect on NB4 and HT93A acute promyelocytic cell lines. Here, in this study, we demonstrated that eight compounds were isolated from this active methanolic part. It was chromatographed on CC repeatedly as shown in [Figure 1](#fig1){ref-type="fig"}. The bioassay determined the active fractions; they were FFII, FFIII, and FFIV. We found that FFII could inhibit growth on NB4 stronger than HT93A, while FFIII showed growth inhibition on both NB4 and HT93A. Interestingly, FFIV exhibited dominantly growth inhibition on HT93A. The differences in the antiproliferative effects of these fractions might arise from the different active compounds themselves and the interactions with the oncoproteins in these acute promyelocytic cell lines, that is, the long and short types of PML-RAR*α* in NB4 and HT93A, respectively.

The antiproliferative effect of FFII might be caused by the presence of 2 triterpenes, that is, friedelin **1**, and 28-hydroxy-3-friedelanone **2**, and one coumarin **3**, namely, 7-methoxy-coumarin. Previously, the cytotoxicity of 28-hydroxy-3-friedelanone against A549-human lung cancer cell line, LLC-mouse Lewis lung carcinoma, HL60-human promyelocytic cell line, and MCF7-human breast cancer cell line were demonstrated. Hence, some triterpenes could strongly induce apoptosis by attending the mitochondrial membrane potential and regulating the expression of Bcl-2 different compasses \[[@B14], [@B24]\]. The IC~50~ (*μ*g/mL) of 7-methoxy-coumarin **3** on HL60 and K562 human chronic leukemia cells was also demonstrated with the values of 28.9 and 19.3 *μ*g/mL, respectively \[[@B25], [@B26]\].

For FFIII, the cytotoxic activity of this fraction might result from coumarins (**4**, and **5**, namely, 6,7-dimethoxy-coumarin, and scopoletin, resp.) including methyl caffeate **6**. The previous reports demonstrated that coumarins could inhibit several human cancer cell lines such as QU-DB large cell lung cancer, and human leukemia HL60 cells \[[@B26], [@B27]\]. The mechanism of action of coumarins was exerted from the inhibition of tubulin polymerization and the induction of cell cycle arrest at G2/M phase \[[@B27]\]. The involvement of cell cycle inhibition might be due to the inhibition of the release of cyclin D1, an essential enzyme in cell cycle progression \[[@B28]\]. Interestingly, high concentration of scopoletin can have antiproliferative effect on lymphoma cell line by inducing apoptosis \[[@B29]\]. In addition, methyl caffeate can inhibit growth of human cervical adenocarcinoma cell line (HeLa) \[[@B30]\]. Notably, methyl caffeate, which contains 2 hydroxyl groups on aromatic ring, can induce cytotoxic activity via the strong antioxidant activity from these hydroxyl groups \[[@B31]\].

FFIV inhibited HT93A stronger than NB4 cells. It contained sitosteryl glucoside **7** and a supposed glycosphingolipid **8**. The partial structures of **8** included two acyl chains, one of which was palmitic acid, *β*-*D*-glucose, and an amino alcohol. ^1^H-NMR spectrum of **8** showed that the typical resonances of amino alcohol part of glycosphingolipid were H-1a at *δ* 4.24 (1H, m), H-1b 4.66 (1H, m), and H-2 and H-3 4.75 (2H, m) ([Figure 5](#fig5){ref-type="fig"}) \[[@B3], [@B22]\]. One acyl chain was biosynthetically originated from palmitoyl-CoA which was shown by the long chain methylene protons of **8** appearing as multiplets at *δ* 1.1--1.3 \[[@B23]\]. The presence of sugar protons as complex multiplets at *δ* 3.90--4.50 ppm (7H, m, from H-1′′ to H-6′′) was substantiated by carbon signals at *δ* 105.6 (C1′′), 75.4 (C2′′), 78.6 (C3′′), 71.8 (C4′′), 78.4 (C5′′), and 63.0 (C6′′). The structure of **8** was thus supposed to be a glycosphingolipid. The sitosteryl glucoside **7** was previously reported to have the antiproliferative effect on human colon cancer cell by inducing the apoptotic pathway \[[@B31]\]. The glycosphingolipid **8**, which contains sphingosine, can induce apoptosis involving with the ceramide and sphingosine-1-phosphate-mediated pathway \[[@B32], [@B33]\]. The result from our study pointed out that coumarins were promising anticancer agent \[[@B34]\]. The extract fraction containing mainly coumarins like FFIII could be developed as a drug material for anticancer phytopharmaceutical.

5. Conclusion {#sec5}
=============

The methanolic part of *P. indica* extract inhibited the acute promyelocytic leukemia cell lines, NB4, and HT93A. The bioassay-guided fractionation of the active part got three different active fractions. They were FFII, FFIII, and FFIV. The FFII showed strong growth inhibition on NB4, whereas the FFIII exhibited strong growth inhibition on both NB4 and HT93A. The FFIV demonstrated strong growth inhibition on HT93A. The active compounds isolated from the FFII contained mainly triterpenoids (friedelin **1** and 28-hydroxy-3-friedelanone **2**) and some coumarins (7-methoxy-coumarin **3**). The FFIII contained mainly phenolic compounds (scoparone **4**, scopoletin**5**, and methyl caffeate**6**), and the FFIV contained mainly glycosides (sitosteryl glucoside**7** and glycosphingolipid **8**). *P. indica* was the first report about antiproliferative effect on human leukemic cell lines, and the structures of compounds **1**--**8** were elucidated. The further investigation including drug development will be studied on these fractions especially the FFIII which demonstrated the best antiproliferative effect on both human leukemic cell lines (NB4 and HT93A).
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